medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2014, Number 2

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2014; 30 (2)

Acute chest syndrome in children with sickle cell disease at the Institute of Hematology and Immunology

Roque GW, Svarch E, Quesada LY, Gutiérrez DA

Language: Spanish
References: 20
Page: 137-145
PDF size: 153.95 Kb.


ABSTRACT

Introduction: acute chest syndrome describes new respiratory symptoms and new pulmonary infiltrate in chest radiograph in patients with sickle cell disease, and is the second most common cause of hospitalization in these children.
Objectives: to get acquainted with clinical and laboratory features and the treatment used in each episode of acute chest syndrome.
Methods: an ambispective and analitic study was conducted involving 112 episodes of acute chest syndrome in 62 patients admitted to the Pediatric Service of the Institute of Hematology and Inmunology from January 1st 2005 through July 30th 2012.
Results: the syndrome was more frequent in male children (58,06 %) between 5-9 years old and in sickle cell anemia patients (67,85 %). Only one episode occurred in 54,8% of the children and the rest presented two or more. Fever, chest pain and cough were the main features at diagnosis. X-ray findings showed that the right lung base was involved in 52% of the cases. All our patients received antibiotic, mainly cefotaxima, azitromicin and ceftriaxone. In 83 episodes blood therapy was applied. We found statistical correlation between white cell count at diagnosis and the severity of the episode (p = 0.009). No mortality associated to acute chest syndrome occurred.
Conclusions: the acute chest syndrome was present in the patients studied with similar characteristics reported by other authors. A correct health education to patientes and family members, together with a precise and early diagnosis and treatment directed by a specialized medical team were significant for the survival of all our patients.


REFERENCES

  1. Colombo S, Svarch E, Martínez G. Introducción al estudio de las hemoglobinopatías. La Habana: Editorial Pueblo y Educación; 1993. p. 146-83.

  2. Charache S, Scott JC, Charache P. "Acute chest syndrome" in adults with sickle cell anemia. Arch Intern Med. 1979 Jan;139(1):67-9.

  3. Hernández-Rivas JA, Nistal S, Heras C, Ruiz M, Foncillas MA, López JC, et al. Complicaciones cardiopulmonares en la enfermedad drepanocítica. Haematologica (edición española). 2011;96 (Extra 1):100-2.

  4. Johnson CS. The acute chest syndrome. Hematol Oncol Clin N Am. 2005 Oct;19(5):857-79.

  5. Gladwin MT, Kato GJ, Weiner D, Onyekwere OC, Dampier C, Hsu L, et al. Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial. JAMA. 2011 Mar;305(9):893-902.

  6. Chiang EY, Frenett PS. Sickle cell vaso-occlusion. Hematol Oncol Clin North Am. 2005 Oct;(5):771-84.

  7. Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D et al. Causes and outcomes of the chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Eng J Med. 2000 Jun;342(25):1855-65.

  8. Ballas SK, Lieff S, Benjamin LJ, Dampier CD, Heeney MM, Hoppe C, et al. Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol. 2010 Jan;85(1):6-13.

  9. Johnson CS. The acute chest syndrome. Hematol Oncol Clin N Am. 2005 Oct;19(5):857-79.

  10. Kokoska ER, West KW, Carney DE, Engum SE, Heiny ME, Rescorla FJ. Risk factors for acute chest syndrome in children with sickle cell disease undergoing abdominal surgery. J Pediatr Surg. 2004 Jun;39(6):848-50.

  11. Quinn CT, Shull EP, Ahmad N, Lee NJ, Rogers ZR, Buchanan GR. Prognostic significance of early vasoocclusive complications in children with sickle cell anemia. Blood. 2007 Jan;109(1):40-5.

  12. Morris C, Vichinsky E, Styles L. Clinician assessment for acute chest syndrome in febrile patients with sickle cell disease: is it accurate enough? Ann Emerg Med. 1999 Jul;34(1):64-9.

  13. Martin L, Buonomo C. Acute chest syndrome cell of sickle disease: radiographic and clinical analysis of 70 cases. Pediatric Radiol. 1997 Aug;27(8):637-41.

  14. Velasquez MP, Mariscalco MM, Goldstein SL, Airewele GE. Erythrocytapheresis in children with sickle cell disease and acute chest syndrome. Pediatric Blood Cancer. 2009 Dec;53(6):1060-3.

  15. Alhashimi D, Fedorowicz Z, Alhashimi F, Dastgiri S. Blood transfusions for treating acute chest syndrome in people with sickle cell disease. Cochrane Database Syst Rev. 2010;1:1-12.

  16. Turner JM, Kaplan JB, Cohen HW, Billet HH. Exchange versus simple transfusion for acute chest syndrome in sickle cell anemia adults. Transfusion. 2009 May;49(5):863-8.

  17. Maitre B, Habibi A, Roudot-Thoraval F, Bachir D, Belghiti DD, Galacteros F. et al. Acute chest syndrome in adults with sickle cell disease: Therapeutic approach, outcome, and results of BAL in a monocentric series of 107 episodes. Chest. 2000 May;117(5):1386-92.

  18. Normas para el tratamiento de la drepanocitosis. Grupo Nacional de Hematología y Bancos de Sangre. La Habana: Instituto de Hematología e Inmunología, 2013. [acceso: 21 de julio de 2013]. Disponible en: http://www.sld.cu/sitios/hematologia

  19. Kato GJ, Hebbel RP, Steinberg MH, Gladwin MT. Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions. Am J Hematol. 2009 Sep;84(9):618-25.

  20. Chang J, Shi PA, Chiang EY, Frenette PS. Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion. Blood. 2008 Jan;111(2):915-23.




2020     |     www.medigraphic.com